Anna Condella, MD, Edwin G. Lindo, JD, Jenelle Badulak, MD, Nicholas J. Johnson, MD, Rebecca Maine, MD, MPH, Samuel Mandell, MD, MPH,James A. Town, MD, Andrew M. Luks, MD, Shelby Elizaga, ARNP, Eileen M. Bulger, MD, and Barclay T. Stewart, MD, PhD
From National Institute of Health; National Library of Medicine: Extracorporeal membrane oxygenation (ECMO) has emerged in the COVID-19 pandemic as a potentially beneficial yet scarce resource for treating critically ill patients, with variable allocation across the United States. The existing literature has not addressed barriers patients may face in access to ECMO as a result of healthcare inequity. Read the full article here.
